New Trial to Compare Rituximab With Targeted Therapies in Patients With Neuromyelitis Optica Spectrum Disorder by Madaline Spencer| Published on: Jun 3, 2026

New Trial to Compare Rituximab With Targeted Therapies in Patients With Neuromyelitis Optica Spectrum Disorder by Madaline Spencer| Published on: Jun 3, 2026 Sumaira Ahmed, Founder and Executive Director of The Sumaira Foundation, discusses her organization and the BEST-NMOSD clinical trial for patients with neuromyelitis optica spectrum disorder (NMOSD). https://checkrare.com/new-trial-to-compare-rituximab-with-targeted-therapies-in-patients-with-neuromyelitis-optica-spectrum-disorder/